Myob Group (MYO) Stock Price, News & Analysis

Company Overview

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 3.45%
• Price Target: N/A
• Consensus Rating: N/A

MYO Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Myob Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Myob Group investors own include Alibaba Group (BABA), CXApp (CXAI), American Airlines Group (AAL), PACCAR (PCAR), Palantir Technologies (PLTR), Arista Networks (ANET) and Banc of California (BANC).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Manufacturing
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: ASX:MYO
• CUSIP: N/A
• CIK: N/A
• Web: N/A
• Phone: (617) 996-9058
• Fax: N/A
• Employees: 90
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 585,262,976
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A